Latest Regulatory News

Carnarvon Energy is gearing up for a high-impact Bedout Sub-basin drilling campaign in the first half of 2027, supported by a robust balance sheet and strategic investments.

EVE Health Group has appointed Ben Rohr as CEO, shifting Damian Wood to focus on regulatory and clinical affairs, aiming to sharpen commercial execution amid ongoing product rollouts.

BPM Minerals has completed key surveys at its Bonnie & Clyde Prospect within the Forelands Gold Project, setting the stage for maiden drilling in Q3 2026. The project’s geological complexity and strong geochemical anomalies underline its potential for a major gold discovery.

ECS Botanics reports a third straight quarter of positive operating cash flow, driven by strong B2C growth and strategic international shipments to Germany and New Zealand.

Elevate Uranium Ltd pushes back its U-pgradeTM pilot plant results to August 2026 amid operational tweaks, while reporting a doubled resource grade at Marenica and a 76.2 Mlb uranium resource at Koppies.

Black Canyon Limited has delivered robust metallurgical results confirming high-quality direct shipping ore (DSO) potential for manganese and iron at its Wandanya Project, alongside commencing a major 15,000m drilling campaign to define and expand resources.

Carnavale Resources has secured a key mining lease and reported robust high-grade gold drilling results at Kookynie, keeping its Bankable Feasibility Study on track for early Q3 2026 delivery.

Antipa Minerals completed its CY2025 drilling program at the Minyari Gold-Copper Project, revealing new high-grade zones and boosting its Mineral Resource Estimate to 3.6 million ounces gold equivalent. The company is progressing its Pre-Feasibility Study and has commenced a major new drilling campaign, supported by a strong cash position.

Santana Minerals advanced its Bendigo-Ophir Gold Project in New Zealand with a confirmed consent decision date, major equipment agreements, and a substantial capital raise, setting the stage for development.

TruScreen Group has met its FY2026 revenue guidance with a 41% jump in product sales, while investing heavily in new markets and pursuing a major UNITAID funding bid that could reshape its medium-term outlook.

AuKing Mining has bolstered its project portfolio with the acquisition of a Tasmanian tin and silver licence and the Malawi-based Tundulu Rare Earths Project, supported by $5 million in recent equity placements.

Bio-Gene Technology is progressing critical toxicology studies for Flavocide with a targeted APVMA submission in March 2027, while forging a strategic partnership to launch Qcide insecticides in Japan by late 2026.